Fhit protein inhibits cell growth by attenuating the signaling mediated by nuclear factor-κB in colon cancer cell lines

This publication has 30 references indexed in Scilit:

• Enhanced Chemosensitivity to Irinotecan by RNA Interference-Mediated Down-Regulation of the Nuclear Factor-κB p65 Subunit
  Clinical Cancer Research, 2004
• Immunohistochemical expression of FHIT gene product in inflammatory bowel disease
  European Journal of Gastroenterology & Hepatology, 2003
• Effect of proteasome inhibition on cellular oxidative damage, antioxidant defences and nitric oxide production
  Journal of Neurochemistry, 2001
• Enhancement of Oxidative Damage to Cultured Cells and Caenorhabditis elegans by Mitochondrial Electron Transport Inhibitors
  IUBMB Life, 2001
• Frequent Altered Expression of Fragile Histidine Triad Protein in Human Colorectal Adenomas
  Biochemical and Biophysical Research Communications, 2000
• Pervanadate-induced Nuclear Factor-κB Activation Requires Tyrosine Phosphorylation and Degradation of IκBα
  Published by Elsevier ,2000
• Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis
  Science, 1995
• Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway.
  Genes & Development, 1995
• Translocation t(3;8)(p14.2;q24.1) in renal cell carcinoma affects expression of the common fragile site at 3p14(FRA3B) in lymphocytes
  Cancer Genetics and Cytogenetics, 1988
• 5′,5‴-P¹, P⁴Diadenosine Tetraphosphate (Ap₄A): A Putative Initiator of DNA Replication
  Cancer Investigation, 1985